Bainbridge Health CEO Joseph Kaupp makes this analogy to explain his company’s renewed focus: If the platform they’ve been working on so far was just Microsoft Word, they’re now bringing to market the full Microsoft Office suite.

Founded in 2016 as a spinout from the Children’s Hospital of Philadelphia (CHOP), the first move from the company was a medication management software platform using data from infusion pumps to ensure applications were error-proof.

Now — backed by an infusion of $1.6 million from BioAdvance, CHOP, Chestnut Street Ventures and private investors — Bainbridge is working on the expansion of its platform, one that seeks to combat a leading cause of death in the country: medical errors. All told, the company has raised a $3.5 million seed round split up in different tranches.

READ FULL ARTICLE HERE